229 related articles for article (PubMed ID: 26417876)
41. Impact of pretransplant renal function on survival after liver transplantation.
Gonwa TA; Klintmalm GB; Levy M; Jennings LS; Goldstein RM; Husberg BS
Transplantation; 1995 Feb; 59(3):361-5. PubMed ID: 7871566
[TBL] [Abstract][Full Text] [Related]
42. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
[TBL] [Abstract][Full Text] [Related]
43. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
44. Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis.
Ye F; Ying-Bin X; Yu-Guo W; Hetzer R
J Heart Lung Transplant; 2009 Jan; 28(1):58-66. PubMed ID: 19134532
[TBL] [Abstract][Full Text] [Related]
45. Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
Mangus RS; Lutz AJ; Fridell JA; Kubal CA; Bush WJ; Tector AJ
Transplantation; 2015 Sep; 99(9):1855-61. PubMed ID: 26308416
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for prolonged hospitalization after kidney transplants.
Matas AJ; Gillingham KJ; Elick BA; Dunn DL; Gruessner RW; Payne WD; Sutherland DE; Najarian JS
Clin Transplant; 1997 Aug; 11(4):259-64. PubMed ID: 9267712
[TBL] [Abstract][Full Text] [Related]
47. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
Jardine AG; Fellström B; Logan JO; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Pedersen T; Holdaas H
Am J Kidney Dis; 2005 Sep; 46(3):529-36. PubMed ID: 16129216
[TBL] [Abstract][Full Text] [Related]
48. Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.
Kubal C; Cockwell P; Gunson B; Jesky M; Hanvesakul R; Dronavalli V; Bonser RS; Neil D
Transplantation; 2012 Feb; 93(4):406-11. PubMed ID: 22217532
[TBL] [Abstract][Full Text] [Related]
49. Study of the renal function in nonrenal organ transplantation.
Diez Ojea B; Gago González E; Díaz Corte C; Díaz Molina B; Dieguez L; Ortega Suárez F; Alvarez Grande J
Transplant Proc; 2006 Nov; 38(9):2985-8. PubMed ID: 17112881
[TBL] [Abstract][Full Text] [Related]
50. End-stage renal disease after orthotopic heart transplantation: a single-institute experience.
Chen YC; Chou NK; Hsu RB; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Tsao CI; Ko WJ; Wang SS
Transplant Proc; 2010 Apr; 42(3):948-51. PubMed ID: 20430213
[TBL] [Abstract][Full Text] [Related]
51. Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment.
Wissing KM; Pipeleers L
Transplant Rev (Orlando); 2014 Apr; 28(2):37-46. PubMed ID: 24507957
[TBL] [Abstract][Full Text] [Related]
52. Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients.
Kaplinsky E; González-Costello J; Manito N; Roca J; Barbosa MJ; Nebot M; Salazar-Mendiguchia J; Berdejo J; Mañas P; Miralles A; Cequier A
Transplant Proc; 2012 Nov; 44(9):2564-6. PubMed ID: 23146455
[TBL] [Abstract][Full Text] [Related]
53. Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation.
Milongo D; Bascands JL; Huart A; Esposito L; Breuil B; Moulos P; Siwy J; Ramírez-Torres A; Ribes D; Lavayssière L; Del Bello A; Muscari F; Alric L; Bureau C; Rostaing L; Schanstra JP; Kamar N
Liver Int; 2015 Jul; 35(7):1893-901. PubMed ID: 25515948
[TBL] [Abstract][Full Text] [Related]
54. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
[TBL] [Abstract][Full Text] [Related]
55. Predictors of decline in renal function after lung transplantation.
Barraclough K; Menahem SA; Bailey M; Thomson NM
J Heart Lung Transplant; 2006 Dec; 25(12):1431-5. PubMed ID: 17178337
[TBL] [Abstract][Full Text] [Related]
56. Composite risk factors predict survival after transplantation for congenital heart disease.
Kavarana MN; Savage A; O'Connell R; Rubinstein CS; Flynn-Reeves J; Joshi K; Stroud MR; Ikonomidis JS; Bradley SM
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):888-93. PubMed ID: 23886031
[TBL] [Abstract][Full Text] [Related]
57. [Posttransplant complications in cardiac transplant recipients at National Cardiovascular Center].
Kato T; Nakatani T; Kitamura S
Kyobu Geka; 2007 Oct; 60(11):963-8. PubMed ID: 17926898
[TBL] [Abstract][Full Text] [Related]
58. Prevalence and associated comorbidities of moderate to severe chronic renal impairment in Chinese nursing home older adults.
Chan TC; Yap DY; Shea YF; Luk KH; Chan HW; Chu LW
J Am Med Dir Assoc; 2012 Sep; 13(7):630-3. PubMed ID: 22698953
[TBL] [Abstract][Full Text] [Related]
59. Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors.
Tinti F; Mitterhofer AP; Muiesan P
Minerva Chir; 2012 Feb; 67(1):1-13. PubMed ID: 22361672
[TBL] [Abstract][Full Text] [Related]
60. Long-term renal function in pediatric liver and heart recipients.
Alonso EM
Pediatr Transplant; 2004 Aug; 8(4):381-5. PubMed ID: 15265166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
